News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ready
PBM, new 52 week low
Many reason to like $PBM here
~ With RFK this psychedelic stock is a no brainer.
~ $9 mil cash on hand. 3 years worth of CASH
~ Almost double its market cap in CASH (trading at 50% discount to MC)
~ PBM has 0 dilution and 0 shares to borrow ~ 320% CTB
~ 2 Imminent Catalyst:
1 Trial like $MNMD
1 Trial like $QNTM
1 Phase 2b data coming like $QNTM which ran 500%
Thanks...liking PBM a lot here....
Looking good here
Wow 400K premarket block!
Albert Garcia-Romeu, PhD
Associate Professor;
Associate Center Director;
Susan Hill Ward Professor in Psychedelics and Consciousness
Albert Garcia-Romeu, Ph.D. is an Associate Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. He earned his doctorate in psychology in 2012 from Sofia University in Palo Alto, CA where he studied self-transcendence, spiritual experiences, and their relationship to mental health. He completed a postdoctoral fellowship in behavioral pharmacology at the Johns Hopkins School of Medicine where he trained in the conduct of clinical research with psychedelics, and subsequently joined the faculty. Dr. Garcia-Romeu has authored numerous peer-reviewed articles, book chapters, and commentaries on psychopharmacology and mental health. His work has been featured in the New York Times, National Geographic, Science, Nature, Psychology Today, People, Time, USA Today, CNN, ESPN, BBC, the Guardian, Gentlemen's Quarterly, the New Republic, Forbes, Scientific American, and the Proceedings of the National Academies of Science, among others. His current research interests include clinical applications of psychedelics, real-world drug use patterns, diversity in science, and the role of spirituality in mental health. He is a founding member of the Johns Hopkins Center for Psychedelic and Consciousness Research and the International Society for Research on Psychedelics. He serves on the Board of Directors for the College on Problems of Drug Dependence (CPDD) and is an Associate Editor for the journal Psychedelic Medicine.
https://hopkinspsychedelic.org/garcia-romeu
Psyence Biomed Names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board
https://www.globenewswire.com/news-release/2025/02/26/3032890/0/en/Psyence-Biomed-Names-Albert-P-Garcia-Romeu-Ph-D-as-Chair-of-its-Newly-Created-Scientific-Advisory-Board.html
There we go.
RFK confirmed. Sector will heat up.
Here we go!
There is no way this doesn't hit 10+ in the near term. The flat on this is crazy low. and the short interest is nutty high. Will spring fast and hard when it goes.
Is this seriously at 43% Short Interest with sub 1M shares outstanding? Talk about squeeze potential. I took a chunk of this!
Over Reaction At This Moment.
Good Things Are Coming!
This beast not over 500 k float. Should be able to get double digits. Hold these.
Loaded up holding for while.
|
Followers
|
5
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
89
|
|
Created
|
03/06/24
|
Type
|
Free
|
| Moderators | |||
AI
